Document is current
Any future updates will be listed below
-
Authors
Griffiths, Gareth
Fitzgerald, Richard
Jaki, Thomas
Corkhill, Andrea
Marwood, Ellice
Reynolds, Helen
Stanton, Louise
Ewings, Sean
Condie, Susannah
Wrixon, Emma
Norton, Andrea
Radford, Mike
Yeats, Sara
Robertson, Jane
Darby-Dowman, Rachel
Walker, Lauren
Khoo, Saye
,
-
Funding
Funding for this research was provided by:
Cancer Research UK (C1522/A25352)
UK National Institute for Health Research (Southampton CTU)
- License Information
-
More Information
Article History
Received: 27 May 2020
Accepted: 30 May 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: West Midlands - Edgbaston Research Ethics Committee (REC reference: 20/WM/0136), 12/05/2020, ,I certify that this trial has received appropriate ethical approval as described above.We will obtain consent from all participants entering into AGILE_ACCORD. If the patient lacks capacity to give consent due to the severity of their medical condition (e.g. patients with WHO clinical severity scores of 6 (hospitalised, intubation and mechanical ventilation) and 7 (ventilation and additional organ support – pressors, renal replacement therapy (RRT), extracorporeal membrane oxygenation (ECMO)), then in the first instance, consent may be obtained from the patient’s personal legal representative.
: Not applicable.
: The authors declare that they have no competing interests.
